|
TAF9 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.879400E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.337600E-01 |
| Normal-vs-Stage2 |
4.233400E-01 |
| Normal-vs-Stage3 |
5.730000E-01 |
| Normal-vs-Stage4 |
3.390600E-01 |
| Stage1-vs-Stage2 |
8.764600E-01 |
| Stage1-vs-Stage3 |
1.016230E-01 |
| Stage1-vs-Stage4 |
8.692200E-01 |
| Stage2-vs-Stage3 |
2.472000E-01 |
| Stage2-vs-Stage4 |
9.907400E-01 |
| Stage3-vs-Stage4 |
1.875980E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.387000E-01 |
| Normal-vs-AfricanAmerican |
3.943400E-01 |
| Normal-vs-Asian |
3.659200E-01 |
| Caucasian-vs-AfricanAmerican |
6.546000E-01 |
| Caucasian-vs-Asian |
2.616600E-01 |
| AfricanAmerican-vs-Asian |
2.196800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.970200E-01 |
| Normal-vs-Female |
1.177010E-01 |
| Male-vs-Female |
1.285360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.520060E-02 |
| Normal-vs-Age(41-60Yrs) |
8.022600E-01 |
| Normal-vs-Age(61-80Yrs) |
3.325900E-02 |
| Normal-vs-Age(81-100Yrs) |
6.385200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.209900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.173900E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.020000E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.232380E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.467600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.470400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.394200E-01 |
| Normal-vs-Grade 2 |
5.809700E-02 |
| Normal-vs-Grade 3 |
8.683400E-01 |
| Normal-vs-Grade 4 |
5.880200E-01 |
| Grade 1-vs-Grade 2 |
8.848200E-01 |
| Grade 1-vs-Grade 3 |
5.477200E-01 |
| Grade 1-vs-Grade 4 |
4.756400E-01 |
| Grade 2-vs-Grade 3 |
3.530000E-02 |
| Grade 2-vs-Grade 4 |
5.413700E-02 |
| Grade 3-vs-Grade 4 |
6.444000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.377800E-03 |
| Normal-vs-ccB subtype |
5.937700E-02 |
| ccA subtype-vs-ccB subtype |
3.6783000001428E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.950400E-01 |
| Normal-vs-N1 |
2.581000E-01 |
| N0-vs-N1 |
3.195800E-01 |
|
|
